A new federal grant will help the University of Florida expand its leadership role in training the next generation of leading scientists in genomic medicine. The National Institutes of Health and the National Human Genome Research Institute awarded a five-year T32 grant worth $1.4 million that will provide postdoctoral research training opportunities in genomic medicine. The grant will be housed in the UF College of Pharmacy and supported by faculty throughout UF Health. Trainees accepted into the Program for Applied Research and Development in Genomic Medicine, or PARADIGM, program will receive extensive mentoring from world-renowned scientists at UF and valuable clinical exposure in multiple areas of genomic medicine, including pharmacogenomics, disease genetics and genomics and cancer genomics.
Julie Johnson, Pharm.D., dean and distinguished professor in the UF College of Pharmacy, and Thomas Pearson, M.D., Ph.D., executive vice president for research and education at UF Health, will serve as principal investigators and program directors of the grant. The overall program includes 36 faculty mentors performing genomic medicine-related research at UF.
The latest grant adds to an impressive lineup of UF Health-sponsored T awards among the academic colleges. UF Health currently sponsors 17 T Awards, including 14 T32 Awards that support pre- and postdoctoral training.